1. Home
  2. RGEN vs KNX Comparison

RGEN vs KNX Comparison

Compare RGEN & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KNX
  • Stock Information
  • Founded
  • RGEN 1981
  • KNX 1989
  • Country
  • RGEN United States
  • KNX United States
  • Employees
  • RGEN N/A
  • KNX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KNX Trucking Freight/Courier Services
  • Sector
  • RGEN Health Care
  • KNX Industrials
  • Exchange
  • RGEN Nasdaq
  • KNX Nasdaq
  • Market Cap
  • RGEN 8.0B
  • KNX 7.2B
  • IPO Year
  • RGEN N/A
  • KNX 1994
  • Fundamental
  • Price
  • RGEN $127.47
  • KNX $47.34
  • Analyst Decision
  • RGEN Buy
  • KNX Buy
  • Analyst Count
  • RGEN 12
  • KNX 17
  • Target Price
  • RGEN $170.40
  • KNX $54.06
  • AVG Volume (30 Days)
  • RGEN 685.0K
  • KNX 2.7M
  • Earning Date
  • RGEN 07-29-2025
  • KNX 07-23-2025
  • Dividend Yield
  • RGEN N/A
  • KNX 1.53%
  • EPS Growth
  • RGEN N/A
  • KNX 37.21
  • EPS
  • RGEN N/A
  • KNX 0.93
  • Revenue
  • RGEN $650,429,000.00
  • KNX $7,411,973,000.00
  • Revenue This Year
  • RGEN $13.93
  • KNX $3.04
  • Revenue Next Year
  • RGEN $14.35
  • KNX $6.68
  • P/E Ratio
  • RGEN N/A
  • KNX $50.83
  • Revenue Growth
  • RGEN 4.88
  • KNX 1.16
  • 52 Week Low
  • RGEN $102.97
  • KNX $36.69
  • 52 Week High
  • RGEN $182.52
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.11
  • KNX 66.13
  • Support Level
  • RGEN $121.44
  • KNX $43.75
  • Resistance Level
  • RGEN $131.43
  • KNX $45.09
  • Average True Range (ATR)
  • RGEN 4.47
  • KNX 1.18
  • MACD
  • RGEN 0.61
  • KNX 0.37
  • Stochastic Oscillator
  • RGEN 74.57
  • KNX 96.26

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: